Effect of somatostatin infusion on jejunal water and electrolyte transport in a patient with secretory diarrhea due to malignant carcinoid syndrome

Glenn R. Davis, Roger C. Camp, Philip Raskin, Guenter J. Krejs

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

The effect of intravenous somatostatin infusion was investigated in a patient with severe secretory diarrhea due to malignant carcinoid syndrome. Continuous somatostatin infusion for 48 hr (4 μg/kg/hr) reduced stool volume from 2.2 to 0.7 liters/day. Intestinal perfusion studies before intravenous somatostatin infusion revealed decreased water and sodium absorption and jejunal chloride secretion. Somatostatin infusion for 2 hr (8 μg/kg/hr) reversed chloride secretion to absorption and markedly enhanced water and sodium absorption. These results suggest that somatostatin inhibited a secretory component of water and ion movement in the small bowel of the patient with malignant carcinoid syndrome.

Original languageEnglish (US)
Pages (from-to)346-349
Number of pages4
JournalGastroenterology
Volume78
Issue number2
StatePublished - 1980

Fingerprint

Malignant Carcinoid Syndrome
Somatostatin
Electrolytes
Diarrhea
Water
Intravenous Infusions
Chlorides
Sodium
Secretory Component
Water Movements
Perfusion
Ions

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Effect of somatostatin infusion on jejunal water and electrolyte transport in a patient with secretory diarrhea due to malignant carcinoid syndrome. / Davis, Glenn R.; Camp, Roger C.; Raskin, Philip; Krejs, Guenter J.

In: Gastroenterology, Vol. 78, No. 2, 1980, p. 346-349.

Research output: Contribution to journalArticle

@article{e8fe41e9aac74feb80ac9fd372fbdb61,
title = "Effect of somatostatin infusion on jejunal water and electrolyte transport in a patient with secretory diarrhea due to malignant carcinoid syndrome",
abstract = "The effect of intravenous somatostatin infusion was investigated in a patient with severe secretory diarrhea due to malignant carcinoid syndrome. Continuous somatostatin infusion for 48 hr (4 μg/kg/hr) reduced stool volume from 2.2 to 0.7 liters/day. Intestinal perfusion studies before intravenous somatostatin infusion revealed decreased water and sodium absorption and jejunal chloride secretion. Somatostatin infusion for 2 hr (8 μg/kg/hr) reversed chloride secretion to absorption and markedly enhanced water and sodium absorption. These results suggest that somatostatin inhibited a secretory component of water and ion movement in the small bowel of the patient with malignant carcinoid syndrome.",
author = "Davis, {Glenn R.} and Camp, {Roger C.} and Philip Raskin and Krejs, {Guenter J.}",
year = "1980",
language = "English (US)",
volume = "78",
pages = "346--349",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Effect of somatostatin infusion on jejunal water and electrolyte transport in a patient with secretory diarrhea due to malignant carcinoid syndrome

AU - Davis, Glenn R.

AU - Camp, Roger C.

AU - Raskin, Philip

AU - Krejs, Guenter J.

PY - 1980

Y1 - 1980

N2 - The effect of intravenous somatostatin infusion was investigated in a patient with severe secretory diarrhea due to malignant carcinoid syndrome. Continuous somatostatin infusion for 48 hr (4 μg/kg/hr) reduced stool volume from 2.2 to 0.7 liters/day. Intestinal perfusion studies before intravenous somatostatin infusion revealed decreased water and sodium absorption and jejunal chloride secretion. Somatostatin infusion for 2 hr (8 μg/kg/hr) reversed chloride secretion to absorption and markedly enhanced water and sodium absorption. These results suggest that somatostatin inhibited a secretory component of water and ion movement in the small bowel of the patient with malignant carcinoid syndrome.

AB - The effect of intravenous somatostatin infusion was investigated in a patient with severe secretory diarrhea due to malignant carcinoid syndrome. Continuous somatostatin infusion for 48 hr (4 μg/kg/hr) reduced stool volume from 2.2 to 0.7 liters/day. Intestinal perfusion studies before intravenous somatostatin infusion revealed decreased water and sodium absorption and jejunal chloride secretion. Somatostatin infusion for 2 hr (8 μg/kg/hr) reversed chloride secretion to absorption and markedly enhanced water and sodium absorption. These results suggest that somatostatin inhibited a secretory component of water and ion movement in the small bowel of the patient with malignant carcinoid syndrome.

UR - http://www.scopus.com/inward/record.url?scp=0018843338&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018843338&partnerID=8YFLogxK

M3 - Article

VL - 78

SP - 346

EP - 349

JO - Gastroenterology

JF - Gastroenterology

SN - 0016-5085

IS - 2

ER -